$MFA
MFA FINANCIAL, INC. Stock $mfa

$mfa Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000105516024000012 Filed on May 06, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$186.8M	$176.8M
YoY Change	29.43%	33.76%
Cost Of Revenue	$133.3M	$129.0M
YoY Change	33.55%	38.97%
Gross Profit	$81.46M	$69.23M
YoY Change	1040.39%	-29.92%
Gross Profit Margin	43.6%	39.15%
Selling, General & Admin	$32.58M	$37.46M
YoY Change	-1.09%	20.77%
% of Gross Profit	40.0%	54.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$800.0K	$800.0K
YoY Change	-38.46%	-38.46%
% of Gross Profit	0.98%	1.16%
Operating Expenses	$41.05M	$45.95M
YoY Change	-2.58%	9.81%
Operating Profit	$40.41M	$23.27M
YoY Change	-215.5%	-59.13%
Interest Expense		$129.0M
YoY Change		38.97%
% of Operating Profit		554.41%
Other Income/Expense, Net
YoY Change
Pretax Income	$42.29M	$24.26M
YoY Change	-263.11%	-66.67%
Income Tax	$346.0K	$1.049M
% Of Pretax Income	0.82%	4.32%
Net Earnings	$41.95M	$23.21M
YoY Change	-261.78%	-68.11%
Net Earnings / Revenue	22.45%	13.13%
Basic Earnings Per Share	$0.32	$0.14
Diluted Earnings Per Share	$0.32	$0.14
COMMON SHARES
Basic Shares Outstanding	102.1M shares	102.1M shares
Diluted Shares Outstanding	105.2M shares	105.2M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$289.4M	$306.3M
YoY Change	-12.14%	-15.5%
Cash & Equivalents	$289.4M	$306.3M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$395.8M	$410.9M
YoY Change	-3.19%	-5.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$36.48M	$37.16M
YoY Change	-4.85%	-4.49%
Goodwill	$61.08M	$61.08M
YoY Change	0.0%	0.0%
Intangibles	$6.400M	$7.200M
YoY Change	-33.33%	-33.94%
Long-Term Investments	$18.30M	$19.80M
YoY Change	-33.21%	-30.04%
Other Assets	$252.0M	$222.9M
YoY Change	44.83%	34.98%
Total Long-Term Assets	$10.68B	$10.46B
YoY Change	14.51%	17.88%
TOTAL ASSETS
Total Short-Term Assets	$395.8M	$410.9M
Total Long-Term Assets	$10.68B	$10.46B
Total Assets	$11.08B	$10.87B
YoY Change	13.77%	16.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$266.6M	$268.0M
YoY Change	70.28%	71.88%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$302.6M	$304.0M
YoY Change	35.54%	58.61%
LONG-TERM LIABILITIES
Long-Term Debt	$8.891B	$8.686B
YoY Change	17.48%	22.31%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$8.891B	$8.686B
YoY Change	17.48%	22.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$302.6M	$304.0M
Total Long-Term Liabilities	$8.891B	$8.686B
Total Liabilities	$9.194B	$8.990B
YoY Change	18.0%	23.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.844B	-$1.840B
YoY Change	4.68%	8.86%
Common Stock	$1.021M	$1.021M
YoY Change	0.2%	0.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.883B	$1.884B
YoY Change
Total Liabilities & Shareholders Equity	$11.08B	$10.87B
YoY Change	13.77%	16.78%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$41.95M	$23.21M
YoY Change	-261.78%	-68.11%
Depreciation, Depletion And Amortization	$800.0K	$800.0K
YoY Change	-38.46%	-38.46%
Cash From Operating Activities	$46.48M	$53.47M
YoY Change	-40.25%	-522.06%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$181.3M	-$83.50M
YoY Change	-67.14%	-40.63%
Cash From Investing Activities	-$181.3M	-$91.40M
YoY Change	-67.05%	-35.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	147.0M	$78.90M
YoY Change	-67.19%	-58.1%
NET CHANGE
Cash From Operating Activities	46.48M	$53.47M
Cash From Investing Activities	-181.3M	-$91.40M
Cash From Financing Activities	147.0M	$78.90M
Net Change In Cash	12.26M	$40.96M
YoY Change	-150.66%	22.24%
FREE CASH FLOW
Cash From Operating Activities	$46.48M	$53.47M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	2351000	usd
CY2024Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	5011000	usd
CY2023Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	3036000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2024Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	304027000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	336030000	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102082000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102082000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101916000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101916000	shares
CY2024Q1	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	12992000	usd
CY2023Q1	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	7308000	usd
CY2024Q1	us-gaap	Other Operating Income OtherOperatingIncome	1163000	usd
CY2024Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	176831000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	132205000	usd
CY2024Q1	mfa	Interest Expense Asset Backed And Collateralized Financing Agreements InterestExpenseAssetBackedAndCollateralizedFinancingAgreements	123442000	usd
CY2023Q1	mfa	Interest Expense Asset Backed And Collateralized Financing Agreements InterestExpenseAssetBackedAndCollateralizedFinancingAgreements	88880000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	5575000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3956000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	129017000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	92836000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	47814000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	39369000	usd
CY2024Q1	mfa	Reversal Provision For Credit Losses On Residential Whole Loans ReversalProvisionForCreditLossesOnResidentialWholeLoans	-460000	usd
CY2023Q1	mfa	Reversal Provision For Credit Losses On Residential Whole Loans ReversalProvisionForCreditLossesOnResidentialWholeLoans	-13000	usd
CY2024Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	1109000	usd
CY2023Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	0	usd
CY2024Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	47165000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	39382000	usd
CY2024Q1	mfa	Mortgage Loans On Real Estate Gain Loss On Loans At Fair Value MortgageLoansOnRealEstateGainLossOnLoansAtFairValue	-11513000	usd
CY2023Q1	mfa	Mortgage Loans On Real Estate Gain Loss On Loans At Fair Value MortgageLoansOnRealEstateGainLossOnLoansAtFairValue	129174000	usd
CY2024Q1	mfa	Impairment And Other Losses Gains On Securities Available For Sale And Other Assets ImpairmentAndOtherLossesGainsOnSecuritiesAvailableForSaleAndOtherAssets	4776000	usd
CY2023Q1	mfa	Impairment And Other Losses Gains On Securities Available For Sale And Other Assets ImpairmentAndOtherLossesGainsOnSecuritiesAvailableForSaleAndOtherAssets	-2931000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	991000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	3942000	usd
CY2024Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	49941000	usd
CY2023Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	-21208000	usd
CY2024Q1	mfa	Fair Value Changes On Securitized Debt FairValueChangesOnSecuritizedDebt	-22462000	usd
CY2023Q1	mfa	Fair Value Changes On Securitized Debt FairValueChangesOnSecuritizedDebt	-51725000	usd
CY2024Q1	mfa	Origination Servicing And Other Fee Income OriginationServicingAndOtherFeeIncome	7928000	usd
CY2023Q1	mfa	Origination Servicing And Other Fee Income OriginationServicingAndOtherFeeIncome	8976000	usd
CY2024Q1	mfa	Mortgage Loans On Real Estate Gain Loss On Loans At Carrying Value MortgageLoansOnRealEstateGainLossOnLoansAtCarryingValue	418000	usd
CY2023Q1	mfa	Mortgage Loans On Real Estate Gain Loss On Loans At Carrying Value MortgageLoansOnRealEstateGainLossOnLoansAtCarryingValue	0	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1875000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3014000	usd
CY2024Q1	mfa	Noninterest Income Loss Net NoninterestIncomeLossNet	22402000	usd
CY2023Q1	mfa	Noninterest Income Loss Net NoninterestIncomeLossNet	75104000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	25468000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	20630000	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	13044000	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	10233000	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	7042000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	9539000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	46354000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	41702000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	23213000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	72784000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2024Q1	mfa	Net Income Loss Available To Common Stockholders Basic And Participating Securities NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities	14994000	usd
CY2023Q1	mfa	Net Income Loss Available To Common Stockholders Basic And Participating Securities NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities	64565000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.62
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	23213000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	72784000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1828000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1116000	usd
CY2024Q1	mfa	Other Comprehensive Income Loss Change In Fair Value Of Financing Agreements At Fair Value OtherComprehensiveIncomeLossChangeInFairValueOfFinancingAgreementsAtFairValue	0	usd
CY2023Q1	mfa	Other Comprehensive Income Loss Change In Fair Value Of Financing Agreements At Fair Value OtherComprehensiveIncomeLossChangeInFairValueOfFinancingAgreementsAtFairValue	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1828000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1116000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	25041000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	71668000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2024Q1	mfa	Comprehensive Income Loss To Common Stockholders And Participating Securities ComprehensiveIncomeLossToCommonStockholdersAndParticipatingSecurities	16822000	usd
CY2023Q1	mfa	Comprehensive Income Loss To Common Stockholders And Participating Securities ComprehensiveIncomeLossToCommonStockholdersAndParticipatingSecurities	63449000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1899915000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	23213000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-17000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1492000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5986000	usd
CY2024Q1	mfa	Adjustments To Additional Paid In Capital Change In Accrued Dividends Attributable To Stock Based Awards AdjustmentsToAdditionalPaidInCapitalChangeInAccruedDividendsAttributableToStockBasedAwards	-1011000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	35729000	usd
CY2024Q1	mfa	Dividends Dividend Equivalent Rights DividendsDividendEquivalentRights	287000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1828000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1884187000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1500000	usd
CY2024Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	129949	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1988849000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	72784000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	599000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3019000	usd
CY2023Q1	mfa	Adjustments To Additional Paid In Capital Change In Accrued Dividends Attributable To Stock Based Awards AdjustmentsToAdditionalPaidInCapitalChangeInAccruedDividendsAttributableToStockBasedAwards	-375000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	35669000	usd
CY2023Q1	mfa	Dividends Dividend Equivalent Rights DividendsDividendEquivalentRights	86000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1116000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2018606000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	600000	usd
CY2023Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	58505	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	23213000	usd
CY2024Q1	mfa	Residential Whole Loans Gain Loss ResidentialWholeLoansGainLoss	-11095000	usd
CY2023Q1	mfa	Residential Whole Loans Gain Loss ResidentialWholeLoansGainLoss	129174000	usd
CY2024Q1	mfa	Impairment And Other Gains Losses On Debt Securities Available For Sale And Other Portfolio Investments Net ImpairmentAndOtherGainsLossesOnDebtSecuritiesAvailableForSaleAndOtherPortfolioInvestmentsNet	4112000	usd
CY2023Q1	mfa	Impairment And Other Gains Losses On Debt Securities Available For Sale And Other Portfolio Investments Net ImpairmentAndOtherGainsLossesOnDebtSecuritiesAvailableForSaleAndOtherPortfolioInvestmentsNet	-2932000	usd
CY2024Q1	mfa	Net Gain Loss On Real Estate Owned NetGainLossOnRealEstateOwned	735000	usd
CY2023Q1	mfa	Net Gain Loss On Real Estate Owned NetGainLossOnRealEstateOwned	3936000	usd
CY2024Q1	mfa	Accretion And Amortization Of Purchase Discounts AccretionAndAmortizationOfPurchaseDiscounts	3327000	usd
CY2023Q1	mfa	Accretion And Amortization Of Purchase Discounts AccretionAndAmortizationOfPurchaseDiscounts	4507000	usd
CY2024Q1	mfa	Provision For Credit And Valuation Losses On Residential Whole Loans And Other Financial Instruments At Carrying Value ProvisionForCreditAndValuationLossesOnResidentialWholeLoansAndOtherFinancialInstrumentsAtCarryingValue	649000	usd
CY2023Q1	mfa	Provision For Credit And Valuation Losses On Residential Whole Loans And Other Financial Instruments At Carrying Value ProvisionForCreditAndValuationLossesOnResidentialWholeLoansAndOtherFinancialInstrumentsAtCarryingValue	-4000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	23182000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-42879000	usd
CY2024Q1	mfa	Unrealized Gain Loss On Securitized Debt At Fair Value UnrealizedGainLossOnSecuritizedDebtAtFairValue	-20169000	usd
CY2023Q1	mfa	Unrealized Gain Loss On Securitized Debt At Fair Value UnrealizedGainLossOnSecuritizedDebtAtFairValue	-48846000	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	5112000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	28428000	usd
CY2024Q1	mfa	Other Non Cash Losses Included In Net Income OtherNonCashLossesIncludedInNetIncome	14103000	usd
CY2023Q1	mfa	Other Non Cash Losses Included In Net Income OtherNonCashLossesIncludedInNetIncome	5674000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-19397000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	20010000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-6915000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	11471000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	53467000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7337000	usd
CY2024Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	761214000	usd
CY2023Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	459012000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	151664000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	263014000	usd
CY2024Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	402354000	usd
CY2023Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	321626000	usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	305858000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Other Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments	8081000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Other Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments	5755000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	24217000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	33968000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-83496000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	6926000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-91402000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-147433000	usd
CY2024Q1	mfa	Principal Payments On Securities Sold Under Agreements To Repurchase And Other Advances PrincipalPaymentsOnSecuritiesSoldUnderAgreementsToRepurchaseAndOtherAdvances	290021000	usd
CY2023Q1	mfa	Principal Payments On Securities Sold Under Agreements To Repurchase And Other Advances PrincipalPaymentsOnSecuritiesSoldUnderAgreementsToRepurchaseAndOtherAdvances	766604000	usd
CY2024Q1	mfa	Proceeds From Securities Sold Under Agreements To Repurchase With Mark To Market Collateral Provisions ProceedsFromSecuritiesSoldUnderAgreementsToRepurchaseWithMarkToMarketCollateralProvisions	438616000	usd
CY2023Q1	mfa	Proceeds From Securities Sold Under Agreements To Repurchase With Mark To Market Collateral Provisions ProceedsFromSecuritiesSoldUnderAgreementsToRepurchaseWithMarkToMarketCollateralProvisions	640498000	usd
CY2024Q1	mfa	Principal Payments On Financing Agreements With Non Mark To Market Collateral Provisions PrincipalPaymentsOnFinancingAgreementsWithNonMarkToMarketCollateralProvisions	576135000	usd
CY2023Q1	mfa	Principal Payments On Financing Agreements With Non Mark To Market Collateral Provisions PrincipalPaymentsOnFinancingAgreementsWithNonMarkToMarketCollateralProvisions	415443000	usd
CY2024Q1	mfa	Proceeds From Securities Sold Under Agreements To Repurchase With Non Mark To Market Collateral Provisions ProceedsFromSecuritiesSoldUnderAgreementsToRepurchaseWithNonMarkToMarketCollateralProvisions	482499000	usd
CY2023Q1	mfa	Proceeds From Securities Sold Under Agreements To Repurchase With Non Mark To Market Collateral Provisions ProceedsFromSecuritiesSoldUnderAgreementsToRepurchaseWithNonMarkToMarketCollateralProvisions	778400000	usd
CY2024Q1	mfa	Payments Made For Securitization Related Cost PaymentsMadeForSecuritizationRelatedCost	1340000	usd
CY2023Q1	mfa	Payments Made For Securitization Related Cost PaymentsMadeForSecuritizationRelatedCost	4602000	usd
CY2024Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	39831000	usd
CY2023Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	110626000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-20000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1491000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2024Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	8219000	usd
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	8219000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	35789000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	35769000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	78895000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	188278000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	40960000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	33508000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	488211000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	494081000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	529171000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	527589000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	122746000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	87057000	usd
CY2024Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	19342000	usd
CY2023Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	20925000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	36015000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	35756000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	Organization <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998. The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes. In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders. The Company has elected to treat certain of its subsidiaries as taxable REIT subsidiaries (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate related business (see Note 8).</span></div>
CY2023Q4	mfa	Loans Including Fair Value Loans Credit Impaired Loans And Other Loans At Carrying Value LoansIncludingFairValueLoansCreditImpairedLoansAndOtherLoansAtCarryingValue	9000000000	usd
CY2024Q1	mfa	Number Of Days Considered To Classify Loans Delinquent NumberOfDaysConsideredToClassifyLoansDelinquent	P60D
CY2024Q1	mfa	Financing Receivable Weighted Average Loan To Value Ratio FinancingReceivableWeightedAverageLoanToValueRatio	0.80
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	306300000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	318000000	usd
CY2024Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	152600000	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	151300000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	222900000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	170200000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7200000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8000000	usd
CY2024Q1	mfa	Commitment Period CommitmentPeriod	P10Y
CY2024Q1	mfa	Loans Including Fair Value Loans Credit Impaired Loans And Other Loans At Carrying Value LoansIncludingFairValueLoansCreditImpairedLoansAndOtherLoansAtCarryingValue	9100000000	usd
CY2024Q1	us-gaap	Allowance For Loan And Lease Losses Real Estate AllowanceForLoanAndLeaseLossesRealEstate	19612000	usd
CY2023Q4	us-gaap	Allowance For Loan And Lease Losses Real Estate AllowanceForLoanAndLeaseLossesRealEstate	20451000	usd
CY2024Q1	mfa	Mortgage Loans On Real Estate Residential MortgageLoansOnRealEstateResidential	9118665000	usd
CY2023Q4	mfa	Mortgage Loans On Real Estate Residential MortgageLoansOnRealEstateResidential	9041292000	usd
CY2024Q1	mfa	Residential Whole Loans ResidentialWholeLoans	25709	loan
CY2023Q4	mfa	Residential Whole Loans ResidentialWholeLoans	25401	loan
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	20451000	usd
CY2024Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-460000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	379000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	19612000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	35314000	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	315000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	2567000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	33062000	usd
CY2024Q1	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	3300000	usd
CY2024Q1	mfa	Financing Receivable Modified In Period Number FinancingReceivableModifiedInPeriodNumber	1	loan
CY2024Q1	us-gaap	Financing Receivable Modified Weighted Average Term Increase From Modification FinancingReceivableModifiedWeightedAverageTermIncreaseFromModification	P29M
CY2024Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	100000	usd
CY2023	mfa	Financing Receivable Modified In Period Number FinancingReceivableModifiedInPeriodNumber	5	loan
CY2023	us-gaap	Financing Receivable Modified Weighted Average Term Increase From Modification FinancingReceivableModifiedWeightedAverageTermIncreaseFromModification	P24M
CY2024Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	600000	usd
CY2024Q1	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	0	usd
CY2024Q1	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	0	usd
CY2024Q1	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	0	usd
CY2024Q1	us-gaap	Financing Receivable Originated Three Years Before Latest Fiscal Year FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear	51752000	usd
CY2024Q1	us-gaap	Financing Receivable Originated Four Years Before Latest Fiscal Year FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear	197803000	usd
CY2024Q1	us-gaap	Financing Receivable Originated Five Or More Years Before Latest Fiscal Year FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear	1234815000	usd
CY2024Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1484370000	usd
CY2024Q1	us-gaap	Financing Receivable Year One Originated Current Fiscal Year Writeoff FinancingReceivableYearOneOriginatedCurrentFiscalYearWriteoff	0	usd
CY2024Q1	us-gaap	Financing Receivable Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff FinancingReceivableYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff	0	usd
CY2024Q1	us-gaap	Financing Receivable Year Three Originated Two Years Before Current Fiscal Year Writeoff FinancingReceivableYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff	0	usd
CY2024Q1	us-gaap	Financing Receivable Year Four Originated Three Years Before Current Fiscal Year Writeoff FinancingReceivableYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff	0	usd
CY2024Q1	mfa	Financing Receivable Year Five Originated Four Years Before Current Fiscal Year Writeoff Reversals FinancingReceivableYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoffReversals	-59000	usd
CY2024Q1	us-gaap	Financing Receivable Originated More Than Five Years Before Current Fiscal Year Writeoff FinancingReceivableOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff	438000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	379000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-4112000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	2931000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	0	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	0	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	usd
CY2024Q1	mfa	Impairment And Other Net Loss Gain On Securities ImpairmentAndOtherNetLossGainOnSecurities	4112000	usd
CY2023Q1	mfa	Impairment And Other Net Loss Gain On Securities ImpairmentAndOtherNetLossGainOnSecurities	-2931000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-664000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2024Q1	mfa	Impairment And Other Losses Gains On Securities Available For Sale And Other Assets ImpairmentAndOtherLossesGainsOnSecuritiesAvailableForSaleAndOtherAssets	4776000	usd
CY2023Q1	mfa	Impairment And Other Losses Gains On Securities Available For Sale And Other Assets ImpairmentAndOtherLossesGainsOnSecuritiesAvailableForSaleAndOtherAssets	-2931000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	17698000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	21341000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1828000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1116000	usd
CY2024Q1	mfa	Other Comprehensive Income Loss Available For Sale Securities Adjustment Excluding Cumulative Effect Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentExcludingCumulativeEffectNetOfTaxPortionAttributableToParent	1828000	usd
CY2023Q1	mfa	Other Comprehensive Income Loss Available For Sale Securities Adjustment Excluding Cumulative Effect Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentExcludingCumulativeEffectNetOfTaxPortionAttributableToParent	-1116000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	19526000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	20225000	usd
CY2024Q1	us-gaap	Real Estate Investments RealEstateInvestments	106185000	usd
CY2023Q4	us-gaap	Real Estate Investments RealEstateInvestments	110174000	usd
CY2024Q1	mfa	Commercial Real Estate Owned CommercialRealEstateOwned	22194000	usd
CY2023Q4	mfa	Commercial Real Estate Owned CommercialRealEstateOwned	22717000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	61076000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	61076000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7200000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8000000	usd
CY2024Q1	mfa	Capital Contributions To Loan Origination Partners CapitalContributionsToLoanOriginationPartners	19780000	usd
CY2023Q4	mfa	Capital Contributions To Loan Origination Partners CapitalContributionsToLoanOriginationPartners	19780000	usd
CY2024Q1	mfa	Commercial Loans Receivable CommercialLoansReceivable	45793000	usd
CY2023Q4	mfa	Commercial Loans Receivable CommercialLoansReceivable	51426000	usd
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	104636000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	98924000	usd
CY2024Q1	mfa	Principal Receivable Advances Suspense Accounts And Other PrincipalReceivableAdvancesSuspenseAccountsAndOther	17891000	usd
CY2023Q4	mfa	Principal Receivable Advances Suspense Accounts And Other PrincipalReceivableAdvancesSuspenseAccountsAndOther	24084000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	37158000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	37819000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	67431000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	63097000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	489344000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	497097000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20000000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.075
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	288	property
CY2024Q1	us-gaap	Real Estate Investments RealEstateInvestments	106200000	usd
CY2023Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	300	property
CY2023Q4	us-gaap	Real Estate Investments RealEstateInvestments	110200000	usd
CY2024Q1	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	106100000	usd
CY2023Q4	us-gaap	Real Estate Investments RealEstateInvestments	110174000	usd
CY2022Q4	us-gaap	Real Estate Investments RealEstateInvestments	130605000	usd
CY2024Q1	us-gaap	Real Estate Owned Valuation Allowance Amounts Applied RealEstateOwnedValuationAllowanceAmountsApplied	1267000	usd
CY2023Q1	us-gaap	Real Estate Owned Valuation Allowance Amounts Applied RealEstateOwnedValuationAllowanceAmountsApplied	1052000	usd
CY2024Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	19342000	usd
CY2023Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	20925000	usd
CY2024Q1	mfa	Real Estate Investments Additions RealEstateInvestmentsAdditions	151000	usd
CY2023Q1	mfa	Real Estate Investments Additions RealEstateInvestmentsAdditions	137000	usd
CY2024Q1	mfa	Real Estate Investments Disposals RealEstateInvestmentsDisposals	22215000	usd
CY2023Q1	mfa	Real Estate Investments Disposals RealEstateInvestmentsDisposals	29400000	usd
CY2024Q1	us-gaap	Real Estate Investments RealEstateInvestments	106185000	usd
CY2023Q1	us-gaap	Real Estate Investments RealEstateInvestments	121215000	usd
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	288	property
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	362	property
CY2024Q1	mfa	Gain Loss Recorded On Transfer From Residential Whole Loans To Real Estate Owned GainLossRecordedOnTransferFromResidentialWholeLoansToRealEstateOwned	-1100000	usd
CY2023Q1	mfa	Gain Loss Recorded On Transfer From Residential Whole Loans To Real Estate Owned GainLossRecordedOnTransferFromResidentialWholeLoansToRealEstateOwned	41000	usd
CY2024Q1	mfa	Number Of Real Estate Properties Sold During Period NumberOfRealEstatePropertiesSoldDuringPeriod	73	property
CY2023Q1	mfa	Number Of Real Estate Properties Sold During Period NumberOfRealEstatePropertiesSoldDuringPeriod	93	property
CY2024Q1	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	24200000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	33800000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	2000000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	5000000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	19800000	usd
CY2024Q1	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P36M
CY2024Q1	us-gaap	Derivative Remaining Maturity1 DerivativeRemainingMaturity1	P116M
CY2024Q1	mfa	Derivatives Income On Swap Variable Receive Leg DerivativesIncomeOnSwapVariableReceiveLeg	44177000	usd
CY2023Q1	mfa	Derivatives Income On Swap Variable Receive Leg DerivativesIncomeOnSwapVariableReceiveLeg	33851000	usd
CY2024Q1	mfa	Expense On Swap Fixed Pay Leg ExpenseOnSwapFixedPayLeg	15086000	usd
CY2023Q1	mfa	Expense On Swap Fixed Pay Leg ExpenseOnSwapFixedPayLeg	12034000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	23182000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-40747000	usd
CY2024Q1	mfa	Derivatives Price Alignment Expense On Margin Collateral Received DerivativesPriceAlignmentExpenseOnMarginCollateralReceived	2332000	usd
CY2023Q1	mfa	Derivatives Price Alignment Expense On Margin Collateral Received DerivativesPriceAlignmentExpenseOnMarginCollateralReceived	2278000	usd
CY2024Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	49941000	usd
CY2023Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	-21208000	usd
CY2024Q1	mfa	Financing Agreements Unpaid Principal Balance FinancingAgreementsUnpaidPrincipalBalance	8813253000	usd
CY2024Q1	mfa	Financing Agreements Fair Value And Carrying Value FinancingAgreementsFairValueAndCarryingValue	8685916000	usd
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0452
CY2023Q4	mfa	Financing Agreements Unpaid Principal Balance FinancingAgreementsUnpaidPrincipalBalance	8683152000	usd
CY2023Q4	mfa	Financing Agreements Fair Value And Carrying Value FinancingAgreementsFairValueAndCarryingValue	8536745000	usd
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0433
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	122177000	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	304027000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	336030000	usd
CY2024Q1	mfa	Repurchase Agreements Number Of Counterparties RepurchaseAgreementsNumberOfCounterparties	14	counterparty
CY2023Q4	mfa	Repurchase Agreements Number Of Counterparties RepurchaseAgreementsNumberOfCounterparties	14	counterparty
CY2024Q1	mfa	Repurchase Agreement Counterparty Risk As Percentage Of Stockholders Equity RepurchaseAgreementCounterpartyRiskAsPercentageOfStockholdersEquity	0.05
CY2024Q1	mfa	Payable For Purchase Of Unsettled Securities PayableForPurchaseOfUnsettledSecurities	0	usd
CY2023Q4	mfa	Payable For Purchase Of Unsettled Securities PayableForPurchaseOfUnsettledSecurities	103654000	usd
CY2024Q1	mfa	Dividends And Dividend Equivalents Payable DividendsAndDividendEquivalentsPayable	36015000	usd
CY2023Q4	mfa	Dividends And Dividend Equivalents Payable DividendsAndDividendEquivalentsPayable	35789000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	42873000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	43576000	usd
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	36187000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	30834000	usd
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	188952000	usd
CY2024Q1	mfa	Real Estate Investment Trusts Reit Taxable Income Distribution Objective Percent RealEstateInvestmentTrustsREITTaxableIncomeDistributionObjectivePercent	1
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	87007000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	91113000	usd
CY2024Q1	mfa	Deferred Tax Assets Unrealized Mark To Market Impairments And Loss Provisions DeferredTaxAssetsUnrealizedMarkToMarketImpairmentsAndLossProvisions	16977000	usd
CY2023Q4	mfa	Deferred Tax Assets Unrealized Mark To Market Impairments And Loss Provisions DeferredTaxAssetsUnrealizedMarkToMarketImpairmentsAndLossProvisions	16170000	usd
CY2024Q1	mfa	Deferred Tax Assets Other Realized Unrealized Treatment Differences DeferredTaxAssetsOtherRealizedUnrealizedTreatmentDifferences	-32891000	usd
CY2023Q4	mfa	Deferred Tax Assets Other Realized Unrealized Treatment Differences DeferredTaxAssetsOtherRealizedUnrealizedTreatmentDifferences	-34923000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	71093000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	72360000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	71093000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	72360000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	356600000	usd
CY2024Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	422000	usd
CY2023Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-134000	usd
CY2024Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	111000	usd
CY2023Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-53000	usd
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	533000	usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-187000	usd
CY2024Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	399000	usd
CY2023Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	589000	usd
CY2024Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	117000	usd
CY2023Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	155000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	516000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	744000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1049000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	557000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	36000000	usd
CY2024Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	200000000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	250000000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	202500000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2024Q1	mfa	Effective Income Tax Rate Reconciliation Non Taxable Reit Income Dividends Paid Deduction EffectiveIncomeTaxRateReconciliationNonTaxableREITIncomeDividendsPaidDeduction	-0.245
CY2023Q1	mfa	Effective Income Tax Rate Reconciliation Non Taxable Reit Income Dividends Paid Deduction EffectiveIncomeTaxRateReconciliationNonTaxableREITIncomeDividendsPaidDeduction	-0.090
CY2024Q1	mfa	Effective Income Tax Rate Reconciliation Other Differences In Taxable Income Loss From Gaap EffectiveIncomeTaxRateReconciliationOtherDifferencesInTaxableIncomeLossFromGAAP	0.210
CY2023Q1	mfa	Effective Income Tax Rate Reconciliation Other Differences In Taxable Income Loss From Gaap EffectiveIncomeTaxRateReconciliationOtherDifferencesInTaxableIncomeLossFromGAAP	-0.084
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.002
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.139
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.029
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.034
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.007
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	4553000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5212000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4839000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5119000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5055000	usd
CY2024Q1	mfa	Operating Lease Liability To Be Paid After Year Four OperatingLeaseLiabilityToBePaidAfterYearFour	41944000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	66722000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	23849000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	42873000	usd
CY2024Q1	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	42500000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2023Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	200000000	usd
CY2024Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	1828000	usd
CY2024Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1828000	usd
CY2023Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-1116000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1116000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	23213000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	72784000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	8219000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	8219000	usd
CY2024Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-167000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14827000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	64565000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103173000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102155000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14827000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	64565000	usd
CY2024Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	usd
CY2023Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	3955000	usd
CY2024Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	0	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	14827000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	68520000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103173000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102155000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	7230000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2076000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	956000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105249000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110341000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.62
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	478000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	8500000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4000000	shares
CY2024Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	129949	shares
CY2023Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	58505	shares
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6243000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3020000	usd
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	8390857000	usd
CY2024Q1	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	4065630000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	8257598000	usd
CY2023Q4	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	3985372000	usd
CY2024Q1	mfa	Other Real Estate Fair Value OtherRealEstateFairValue	19300000	usd
CY2023Q1	mfa	Other Real Estate Fair Value OtherRealEstateFairValue	20900000	usd
CY2024Q1	mfa	Loans Including Fair Value Loans Credit Impaired Loans And Other Loans At Carrying Value LoansIncludingFairValueLoansCreditImpairedLoansAndOtherLoansAtCarryingValue	9100000000	usd
CY2023Q4	mfa	Loans Including Fair Value Loans Credit Impaired Loans And Other Loans At Carrying Value LoansIncludingFairValueLoansCreditImpairedLoansAndOtherLoansAtCarryingValue	9000000000	usd
CY2024Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	176831000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	129017000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	47814000	usd
CY2024Q1	mfa	Reversal Provision For Credit Losses On Residential Whole Loans ReversalProvisionForCreditLossesOnResidentialWholeLoans	-460000	usd
CY2024Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	1109000	usd
CY2024Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	47165000	usd
CY2024Q1	mfa	Mortgage Loans On Real Estate Gain Loss On Loans At Fair Value MortgageLoansOnRealEstateGainLossOnLoansAtFairValue	-11513000	usd
CY2024Q1	mfa	Impairment And Other Losses Gains On Securities Available For Sale And Other Assets ImpairmentAndOtherLossesGainsOnSecuritiesAvailableForSaleAndOtherAssets	4776000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	991000	usd
CY2024Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	49941000	usd
CY2024Q1	mfa	Fair Value Changes On Securitized Debt FairValueChangesOnSecuritizedDebt	-22462000	usd
CY2024Q1	mfa	Origination Servicing And Other Fee Income OriginationServicingAndOtherFeeIncome	7928000	usd
CY2024Q1	mfa	Mortgage Loans On Real Estate Gain Loss On Loans At Carrying Value MortgageLoansOnRealEstateGainLossOnLoansAtCarryingValue	418000	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1875000	usd
CY2024Q1	mfa	Noninterest Income Loss Net NoninterestIncomeLossNet	22402000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	25468000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13044000	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	7042000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	23213000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2024Q1	mfa	Net Income Loss Available To Common Stockholders Basic And Participating Securities NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities	14994000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	132205000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	92836000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	39369000	usd
CY2023Q1	mfa	Reversal Provision For Credit Losses On Residential Whole Loans ReversalProvisionForCreditLossesOnResidentialWholeLoans	-13000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	39382000	usd
CY2023Q1	mfa	Mortgage Loans On Real Estate Gain Loss On Loans At Fair Value MortgageLoansOnRealEstateGainLossOnLoansAtFairValue	129174000	usd
CY2023Q1	mfa	Impairment And Other Losses Gains On Securities Available For Sale And Other Assets ImpairmentAndOtherLossesGainsOnSecuritiesAvailableForSaleAndOtherAssets	-2931000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	3942000	usd
CY2023Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	-21208000	usd
CY2023Q1	mfa	Fair Value Changes On Securitized Debt FairValueChangesOnSecuritizedDebt	-51725000	usd
CY2023Q1	mfa	Origination Servicing And Other Fee Income OriginationServicingAndOtherFeeIncome	8976000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3014000	usd
CY2023Q1	mfa	Noninterest Income Loss Net NoninterestIncomeLossNet	75104000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	20630000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10233000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	9539000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	72784000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2023Q1	mfa	Net Income Loss Available To Common Stockholders Basic And Participating Securities NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities	64565000	usd
CY2024Q1	us-gaap	Assets Assets	10874130000	usd
CY2023Q4	us-gaap	Assets Assets	10772690000	usd

Files In Submission

Name	View Source	Status
0001055160-24-000012-index-headers.html	Edgar Link	pending
0001055160-24-000012-index.html	Edgar Link	pending
0001055160-24-000012.txt	Edgar Link	pending
mfa-20240331_cal.xml	Edgar Link	unprocessable
0001055160-24-000012-xbrl.zip	Edgar Link	pending
exhibit311certificationofc.htm	Edgar Link	pending
exhibit312certificationofc.htm	Edgar Link	pending
exhibit321certificationofc.htm	Edgar Link	pending
exhibit322certificationofc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mfa-20240331.htm	Edgar Link	pending
mfa-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
mfa-20240331_def.xml	Edgar Link	unprocessable
mfa-20240331_lab.xml	Edgar Link	unprocessable
mfa-20240331_pre.xml	Edgar Link	unprocessable
mfa-20240331_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MFA
MFA FINANCIAL, INC. Stock $mfa

2024 Q2 Form 10-Q Financial Statement

#000105516024000012 Filed on May 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MFA MFA FINANCIAL, INC. Stock $mfa

2024 Q2 Form 10-Q Financial Statement

#000105516024000012 Filed on May 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MFA
MFA FINANCIAL, INC. Stock $mfa